000 01809 a2200529 4500
005 20250518081818.0
264 0 _c20201130
008 202011s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-019-57153-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, Sylwia
245 0 0 _aTargeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.
_h[electronic resource]
260 _bScientific reports
_c01 2020
300 _a663 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntineoplastic Agents
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aDNA-Binding Proteins
650 0 4 _aEndocytosis
_xdrug effects
650 0 4 _aEndosomal Sorting Complexes Required for Transport
650 0 4 _aEndosomes
_xmetabolism
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLysosomes
_xmetabolism
650 0 4 _aPhosphoproteins
650 0 4 _aProtein Transport
650 0 4 _aReceptors, Cell Surface
650 0 4 _aTranscription Factors
700 1 _aKing, Peter J
700 1 _aAntonescu, Costin N
700 1 _aSugiyama, Michael G
700 1 _aBhamra, Amandeep
700 1 _aSurinova, Silvia
700 1 _aAngelopoulos, Nicos
700 1 _aKragh, Michael
700 1 _aPedersen, Mikkel W
700 1 _aHartley, John A
700 1 _aFutter, Clare E
700 1 _aHochhauser, Daniel
773 0 _tScientific reports
_gvol. 10
_gno. 1
_gp. 663
856 4 0 _uhttps://doi.org/10.1038/s41598-019-57153-9
_zAvailable from publisher's website
999 _c30540145
_d30540145